Bluejay Diagnostics, Inc.
BJDX
$1.17
-$0.05-4.10%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.35% | -4.95% | -30.20% | 3.37% | 40.13% |
| Total Depreciation and Amortization | -17.71% | -26.01% | 38.40% | -30.04% | -0.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,445.45% | -184.62% | 100.26% | -8,873.68% | -98.18% |
| Change in Net Operating Assets | 225.84% | -121.50% | 301.80% | 121.30% | -478.83% |
| Cash from Operations | 33.80% | -73.36% | 31.85% | 19.30% | -12.52% |
| Capital Expenditure | -- | -- | -- | -450.00% | 99.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -450.00% | 99.93% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 0.00% | 0.00% | -100.35% | 292.99% | 91.99% |
| Issuance of Common Stock | -100.00% | -- | -- | -100.00% | -99.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | 100.00% |
| Cash from Financing | -100.03% | 338,200.00% | -100.35% | 293.37% | -101.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.55% | 211.91% | 18.43% | 36.87% | -142.66% |